Aims & Scope
Curated by leading Genetic Engineering & Biotechnology News (GEN) reporters, GEN Edge delivers exclusive news and insights that keep life science researchers, professionals, and industry executives ahead of the competition and on the bleeding-edge of biotech. GEN Edge goes beyond the headlines and cuts through the noise to give early insight into how, when, and why the latest biotech developments will impact future outcomes and investments.
A GEN Edge site-license provides access to critical insider content, including in-depth reporting, profiles of new and emerging companies, market analyses, early indicator intel, Market Insights Reports, and dynamic invitation-only networking events.
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.
